Summary of the IC50s of Delta-24-RGD in Tested Pancreatic Cancer Cell Lines from Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma

Authors :: Jason B. Fleming
Frederick F. Lang
Juan Fueyo-Margareto
Rolf A. Brekken
Michael Pratt
Xinqun Li
Mayrim V. Rios Perez
Joy Gumin
Ya'an Kang
David Roife
Bingbing Dai
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: This table summarizes the dose (multiplicity of infection, MOI) of Delta-24-RGD that causes 50% of viability inhibition of infected pancreatic cancer cell lines (IC50).

Tools